Literature DB >> 2121639

Beta-galactosidase-deficient human fibroblasts: uptake and processing of the exogenous precursor enzyme expressed by stable transformant COS cells.

A Oshima1, K Itoh, Y Nagao, H Sakuraba, Y Suzuki.   

Abstract

COS-1 cells were transfected by electroporation with a cDNA for human acid beta-galactosidase cloned in our laboratory and stable transformants expressing the enzyme activity were selected. The precursor form of the enzyme was secreted in large quantities into the culture medium. The fibroblasts from patients with GM1-gangliosidosis or Morquio B disease showed a remarkable increase of enzyme activity, up to the normal level, after culture in this medium for 2 days; the amount of uptake was essentially the same as that for the precursor form in human fibroblasts. After endocytosis, the precursor molecules were processed normally to the mature form and remained as stable as those produced by human fibroblasts. On the other hand, cells from galactosialidosis patients did not show any increase of enzyme activity in a similar experiment. It was concluded that the transformants are useful as the source of precursor proteins for the study of intracellular turnover of enzyme molecules in mutant cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2121639     DOI: 10.1007/bf00194225

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  20 in total

1.  An EBV-based mammalian cell expression vector for efficient expression of cloned coding sequences.

Authors:  A Jalanko; A Kallio; M Ruohonen-Lehto; H Söderlund; I Ulmanen
Journal:  Biochim Biophys Acta       Date:  1988-02-28

2.  GM1-gangliosidosis. Defective recognition site on beta-galactosidase precursor.

Authors:  A T Hoogeveen; A J Reuser; M Kroos; H Galjaard
Journal:  J Biol Chem       Date:  1986-05-05       Impact factor: 5.157

Review 3.  Trafficking of lysosomal enzymes in normal and disease states.

Authors:  S Kornfeld
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

4.  Cloning, sequencing, and expression of cDNA for human beta-glucuronidase.

Authors:  A Oshima; J W Kyle; R D Miller; J W Hoffmann; P P Powell; J H Grubb; W S Sly; M Tropak; K S Guise; R A Gravel
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

5.  Biosynthesis of lysosomal enzymes in fibroblasts. Synthesis as precursors of higher molecular weight.

Authors:  A Hasilik; E F Neufeld
Journal:  J Biol Chem       Date:  1980-05-25       Impact factor: 5.157

6.  Galactosialidosis: a direct evidence that a 46-kilodalton protein restores deficient enzyme activities in fibroblasts.

Authors:  E Nanba; A Tsuji; K Omura; Y Suzuki
Journal:  Biochem Biophys Res Commun       Date:  1987-04-14       Impact factor: 3.575

7.  Processing of human beta-galactosidase in GM1-gangliosidosis and Morquio B syndrome.

Authors:  A T Hoogeveen; H Graham-Kawashima; A d'Azzo; H Galjaard
Journal:  J Biol Chem       Date:  1984-02-10       Impact factor: 5.157

8.  The relation between human lysosomal beta-galactosidase and its protective protein.

Authors:  A T Hoogeveen; F W Verheijen; H Galjaard
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

9.  Generalized gangliosidosis: beta-galactosidase deficiency.

Authors:  S Okada; J S O'Brien
Journal:  Science       Date:  1968-05-31       Impact factor: 47.728

10.  Galactosialidosis: molecular heterogeneity in biosynthesis and processing of protective protein for beta-galactosidase.

Authors:  E Nanba; A Tsuji; K Omura; Y Suzuki
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

View more
  3 in total

1.  Characterization and purification of human beta-galactosidase overexpressed in recombinant baculovirus-infected Spodoptera frugiperda cells.

Authors:  K Itoh; A Oshima; H Sakuraba; Y Suzuki
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

2.  Human beta-galactosidase gene mutations in GM1-gangliosidosis: a common mutation among Japanese adult/chronic cases.

Authors:  K Yoshida; A Oshima; M Shimmoto; Y Fukuhara; H Sakuraba; N Yanagisawa; Y Suzuki
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

3.  SR proteins and the nonsense-mediated decay mechanism are involved in human GLB1 gene alternative splicing.

Authors:  Raül Santamaria; Lluïsa Vilageliu; Daniel Grinberg
Journal:  BMC Res Notes       Date:  2008-12-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.